Target intelligence / Profile preview

Doublecortin domain-containing protein 2 (DCDC2)

Target
DCDC2
Molecular classification
Other (Tubulin-binding protein; Doublecortin domain family; Microtubule-binding protein)
01

Overview

Doublecortin domain-containing protein 2 (DCDC2) is a microtubule-associated protein containing doublecortin domains, which bind to tubulin and enhance microtubule polymerization[1][2][3]. DCDC2 plays a critical role in *neuronal migration* and *cilia-related signaling* in developing neurons and sensory hair cells, influencing both cortical development and auditory function[1]. Mutations and regulatory variants in DCDC2 have been associated with *developmental dyslexia*, likely by affecting cilia-dependent processes in the brain that govern language and reading function[1][2][3]. Although linked to several rare diseases (including autosomal recessive deafness and neonatal sclerosing cholangitis), DCDC2 is best known for its role in neurodevelopment. There is no evidence that DCDC2 functions as a receptor, transporter, or enzyme, and it is not targeted by current pharmaceuticals[1][2][3].

Other names
DCDC2AKIAA1154RU2RU2SNPHP19DFNB66NSC
02

Mechanism of action

Not applicable—there are no drugs targeting DCDC2 directly

03

Biological functions

Microtubule polymerizationNeuronal migrationModulation of primary cilia signalingRegulation of canonical Wnt signaling pathwayControl of ciliogenesis and ciliary length
04

Disease associations

Neurodevelopmental disorders (particularly developmental dyslexia/reading disability)Deafness (autosomal recessive 66/non‐syndromic recessive deafness)Sclerosing cholangitis (neonatal/NPHP19; rarer association)
05

Safety considerations

No specific safety concerns or therapeutic challenges are described in connection with targeting DCDC2, as it is not a therapeutic target.
06

Biomarkers

No established pharmacological biomarkers for patient selection or efficacy monitoring linked to DCDC2 as a therapeutic target. However, genetic variants in DCDC2 may be used in research settings as markers for susceptibility to developmental dyslexia or related neurodevelopmental phenotypes.

Beyond the preview

Go deeper on Doublecortin domain-containing protein 2 (DCDC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Doublecortin domain-containing protein 2 (DCDC2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call